Evaluation of HER-2/NEU Protein Expression in Breast Cancer by Immunohistochemistry: An Interlaboratory Study Assessing the Reproducibility of HER-2/NEU Testing-Reference-Cited by-同舟云学术

Evaluation of HER-2/NEU Protein Expression in Breast Cancer by Immunohistochemistry: An Interlaboratory Study Assessing the Reproducibility of HER-2/NEU Testing

Published:2002-07 Issue:2 Volume:74 Page:113-120
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Gancberg David,Järvinen Tero,Leo Angelo di,Rouas Ghizlane,Cardoso Fatima,Paesmans Marianne,Verhest Alain,Piccart Martine J.,Isola Jorma,Larsimont Denis

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.springerlink.com/index/pdf/10.1023/A:1016146130767

Reference43 articles.

1. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177–182, 1987.Interlaboratory agreement for HER-2/neu evaluation 119

2. Ross JS, Fletcher JA: HER-2/neu (c-erb-B2) gene and protein in breast cancer. Am J Clin Pathol 112: S53-S67, 1999

3. Harari D, Yarden Y: Molecular mechanisms underlying ErbB2/HER2 action in breast cancer. Oncogene 19: 6002–6114, 2000

4. _Yu D, Hung M-C: Overexpression of ErbB2 in cancer and ErbB2-targeting strategies. Oncogene 19: 6115–6121, 2000

5. Gusterson BA, Gelber RD, Goldhirsch A, Price KN, Säve-Söderborgh J, Anbazhagan R, Styles J, Rudenstam C-M, Golouh R, Martinez-Tello F, Tiltman A, Torhorst J, Grigolato P, Bettelheim R, Neville AM, Bürki K, Castiglione M, Collins J, Lindtner J, Senn JJ: Prognostic importance of c-erbB-2 expression in breast cancer. J Clin Oncol 10: 1049–1056, 1992

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applications of Artificial Intelligence in Breast Pathology;ARCH PATHOL LAB MED;2023

2. Digital image analysis and assisted reading of the HER2 score display reduced concordance: pitfalls in the categorisation of HER2‐low breast cancer;Histopathology;2023-03

3. Applications of Artificial Intelligence in Breast Pathology;Archives of Pathology & Laboratory Medicine;2023-02-16

4. Update on prognostic and predictive biomarkers of breast cancer;Seminars in Diagnostic Pathology;2022-09

5. Clinical tissue biomarker digital image analysis: A review of current applications;Human Pathology Reports;2022-06